VINCIARELLI PATRIZIO sold $5.6M of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 20,000 shares of VICOR CORP (VICR) at an average of $279.50 ($269.59–$300.29, $5.59M total) across 21 trades on 2026-06-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 11, 2026, 8:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 11, 2026, 8:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The CEO/Chairman’s open-market sale of $5.59M could influence short-term sentiment, but the presence of a pre-arranged 10b5-1 plan generally lowers the probability that the sale is based on newly material information.

02

Market read

Traders may monitor for follow-on insider activity, but this specific disclosure is unlikely to be a standalone fundamental catalyst.

03

What to watch

The filing aggregates 21 trades across a wide price range ($269.59–$300.29), so the timing may be driven by plan mechanics rather than a single market view.

Relevance 5/10Novelty 5/10Timing: Filed 2026-06-11; sale executed 2026-06-10.

Background

The article is an SEC Form 4 insider transaction disclosure for Vicor Corp (VICR).

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR Chairman/CEO sold $5.59M of VICR shares in an open-market transaction under a pre-arranged 10b5-1 plan on 2026-06-10.

Expected impact

Likely limited/short-lived impact; any move would be more sentiment-driven than fundamental.

Evidence & confidence

The filing is a primary-source Form 4 showing size ($5.59M) and role (CEO/Chairman), but it explicitly states a pre-arranged 10b5-1 plan, which typically dampens interpretation as a reaction to new information.

Market effects

No direct sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Because the trades were executed under a pre-arranged 10b5-1 plan, the sale may reflect routine liquidity rather than bearish expectations.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider sale; shares sold by its Chairman and CEO.

  • VINCIARELLI PATRIZIO

    Chairman and CEO (and 10% owner) who sold 20,000 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.